TherOx has had a withdrawn IPO, snub from the FDA, but looks like it's rebounding with its promising device that could help salvage damaged heart tissue after a heart attack.
Jawbone plans to take its case up with the International Trade Commission to halt imports of Fitbit components and products.
Medical billing is a tedious administrative task, but outsourcing it may be the key to increased revenue. Explore the top medical billing outsourcing companies and the benefits of partnering with one.
CardioCell's in Phase 2a trials with its stem cell therapy for chronic heart failure. Its approach is to infuse stem cells into a patient's system taht stimulate the heart cells into to working again.